Bluejay Diagnostics, Inc.
BJDX
$2.98
-$0.27-8.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 831.30K | 1.10M | 1.10M | 930.60K | 810.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.62M | 1.99M | 1.89M | 1.48M | 1.36M |
| Operating Income | -1.62M | -1.99M | -1.89M | -1.48M | -1.36M |
| Income Before Tax | -1.60M | -1.96M | -1.86M | -1.43M | -1.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.60M | -1.96M | -1.86M | -1.43M | -1.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.60M | -1.96M | -1.86M | -1.43M | -1.48M |
| EBIT | -1.62M | -1.99M | -1.89M | -1.48M | -1.36M |
| EBITDA | -1.61M | -1.97M | -1.87M | -1.46M | -1.34M |
| EPS Basic | -4.06 | -5.64 | -13.46 | -111.26 | -307.77 |
| Normalized Basic EPS | -2.54 | -3.53 | -8.41 | -6.79 | -19.39 |
| EPS Diluted | -4.06 | -5.64 | -13.46 | -111.26 | -307.77 |
| Normalized Diluted EPS | -2.54 | -3.53 | -8.41 | -6.79 | -19.39 |
| Average Basic Shares Outstanding | 393.60K | 346.80K | 138.50K | 131.70K | 47.80K |
| Average Diluted Shares Outstanding | 393.60K | 346.80K | 138.50K | 131.70K | 47.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |